Research Article
Analysis of Inflammatory Mediators in Type 2 Diabetes Patients
Table 1
Demographic information and laboratory investigations of the T2DM patients.
| Characteristics | Mean ± SD/ (%) | T2DM patients | Healthy controls |
| Age | 52.3 ± 11.5 | 35 ± 7 | Sex | | | Male | 28 (49) | 20 (67%) | Female | 29 (51) | 10 (33%) | Disease duration | | | ≥5 years | 51 (89.4) | NA | <5 years | 6 (10.6) | Height | 158.8 ± 7.8 | 165 ± 10 | Weight | 76.8 ± 13.8 | 73 ± 10.2 | BMI | 30.4 ± 5.2 | NA | HbA1c | 8.2 ± 1.4 | NA | CRP | 11.1 ± 24.6 | NA | Vitamin D | 44.2 ± 20.2 | NA | Hypertension | 38 (67) | 0 | TC | 5.1 ± 1.1 | NA | LDL | 3.1 ± 1.0 | NA | HDL | 1.2 ± 0.4 | NA | TG | 1.6 ± 1.1 | NA | Current smokers | 2 (3.5) | 0 | Treatment (%) | | NA | Insulin | 12 (21) | | Oral | | | (Metformin/sulfonylurea) | 27 (47) | | (Metformin only) | 4 (7) | | Oral + insulin | 9 (16) | | Diet + exercise | 5 (9) | |
|
|
T2DM: type 2 diabetes mellitus; BMI: body mass index; HbA1c: glycated haemoglobin; CRP: C-reactive protein; TC: total cholesterol; LDL: low-density lipoprotein; HDL: high-density lipoprotein; TG: triglycerides. NA: not available.
|